AYTU

AYTU

USD

Aytu BioPharma Inc. Common Stock

$2.180-0.090 (-3.965%)

Real-time Price

Healthcare
Drug Manufacturers - Specialty & Generic
United States

Price Chart

Loading Chart...

Key Metrics

Market Metrics
Company Fundamentals
Trading Stats

Market Metrics

Open

$2.270

High

$2.361

Low

$2.170

Volume

0.14M

Company Fundamentals

Market Cap

19.6M

Industry

Drug Manufacturers - Specialty & Generic

Country

United States

Trading Stats

Avg Volume

1.46M

Exchange

NCM

Currency

USD

52-Week Range

Low $0.95Current $2.180High $2.87

Related News

Analyst Upgrades

Ascendiant Capital Initiates Coverage On Aytu BioPharma with Buy Rating, Announces Price Target of $12

Ascendiant Capital analyst Edward Woo initiates coverage on Aytu BioPharma with a Buy rating and announces Price Target of $12.

View more
Ascendiant Capital Initiates Coverage On Aytu BioPharma with Buy Rating, Announces Price Target of $12
AccessWire

Aytu BioPharma Announces Closing of Upsized At the Market Public Offering of Common Stock with Full Exercise of Overallotment and Conference Call to Discuss First-in-Class Antidepressant EXXUA(TM) Opportunity and Commercialization Plan

Gross proceeds from offering total $16.6 million.Financing led by long-term, healthcare-focused institutional investors, including Aytu's largest shareholders Nantahala Capital Management and Stonepine Capital

View more
Aytu BioPharma Announces Closing of Upsized At the Market Public Offering of Common Stock with Full Exercise of Overallotment and Conference Call to Discuss First-in-Class Antidepressant EXXUA(TM) Opportunity and Commercialization Plan